Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jeong Han | - |
dc.contributor.author | Yim, Hyung Joon | - |
dc.contributor.author | Lee, Kwang Gyun | - |
dc.contributor.author | Kim, Seung Young | - |
dc.contributor.author | Jung, Eun Suk | - |
dc.contributor.author | Jung, Young Kul | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Yeon, Jong Eun | - |
dc.contributor.author | Lee, Hong Sik | - |
dc.contributor.author | Um, Soon Ho | - |
dc.contributor.author | Byun, Kwan Soo | - |
dc.contributor.author | Ryu, Ho Sang | - |
dc.date.available | 2020-11-03T00:43:42Z | - |
dc.date.issued | 2012-04 | - |
dc.identifier.issn | 1936-0533 | - |
dc.identifier.issn | 1936-0541 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/12271 | - |
dc.description.abstract | Purpose There have been reports that radiofrequency ablation (RFA) combined with transarterial chemoembolization (TACE) is as equally effective as surgical resection for the treatment of hepatocellular carcinoma (HCC). This study aimed to evaluate recurrence rate and risk factor of recurrence after RFA combined with TACE for early stage HCC. Methods We reviewed the medical records of the patients who were diagnosed with early stage HCC between March 2006 and August 2008 at Korea University Medical Center and treated with RFA combined with TACE for curative intent (n = 65). Results Recurrence rate was 40% (26 cases) and the time to recurrence was 14.9 months. Cumulative recurrence rate at 1 year was 20% (13 cases) and at 2 years was 33.8% (22 cases). Significant variables for recurrence were: (1) RFA repeated more than one session at initial therapy (P < 0.001) and (2) size of main lesion ≥2 cm (P = 0.047). Conclusions The recurrence rate of combination therapy was considerably high. Regardless of the therapy used, careful post-RFA follow-up is needed, especially if additional treatment is required after the first session or if the main lesion is ≥2 cm at the time of RFA. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Pub. Co. | - |
dc.title | Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s12072-011-9290-y | - |
dc.identifier.scopusid | 2-s2.0-84862850720 | - |
dc.identifier.wosid | 000304610900011 | - |
dc.identifier.bibliographicCitation | Hepatology International, v.6, no.2, pp 505 - 510 | - |
dc.citation.title | Hepatology International | - |
dc.citation.volume | 6 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 505 | - |
dc.citation.endPage | 510 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | PRIMARY LIVER-CANCER | - |
dc.subject.keywordPlus | THERMAL ABLATION | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | LOCAL RECURRENCE | - |
dc.subject.keywordPlus | NATURAL-HISTORY | - |
dc.subject.keywordPlus | SINGLE SESSION | - |
dc.subject.keywordPlus | STAGING-SYSTEM | - |
dc.subject.keywordPlus | TUMORS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Radiofrequency ablation | - |
dc.subject.keywordAuthor | Transarterial chemoembolization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.